Version 3.1 · Jurisdiction: Republic of Panama ·
Entity: Nexura Bio Systems, S.A. — Free Trade Zone · DOC: RUO-PLT-V3.1
Classification: RESTRICTED ZONE — REGISTERED RESEARCHERS
NOTICE: Access to the Premium Platform entails the irrevocable acceptance of all terms. If you do not accept any provision, refrain from continuing.
§ 1. LEGAL NATURE OF THIS AGREEMENT AND ACCEPTANCE
This document constitutes a Restricted Access Agreement, Terms and Conditions of Use, Statement of Responsibility, and Waiver of Civil, Criminal, and Administrative Liability between Nexura Bio Systems, S.A., a corporation organized under the laws of the Republic of Panama and operating under a Free Trade Zone regime (hereinafter, "NEXURA"), and you, as a registered user and authorized purchaser of access to the Premium Digital Platform (hereinafter, "the Researcher").
By clicking "I ACCEPT AND ENTER", the Researcher acknowledges having read, understood, and accepted in their entirety all of the provisions of this Agreement, with full, binding, and irrevocable legal force and effect. If you do not agree with any provision, you must refrain from accessing the Platform.
This Agreement supplements NEXURA's General Terms and Conditions of Sale, the RUO Statement, the Technical Data Sheets, the COAs, and the Privacy Policies, all of which are incorporated by reference.
§ 2. DEFINITIONS
- "Premium Platform": a restricted-access digital environment that provides technical information, research-use guides, protocol calendars, reminders, and scientific educational tools.
- "RUO Compounds": compounds, reagents, synthetic peptides, or peptide analogs classified as Research Use Only, including: BPC-157, TB-500, PT-141, MOTS-C, Retatrutide, Semax, Selank, DSIP, Tesamorelin, GHK-Cu, Epitalon, Ipamorelin, CJC-1295, KPV, NAD+, and others in the current catalog.
- "Researcher": any natural or legal person who gains access by means of an access code provided after the purchase of RUO Compounds.
- "Research Protocol": a structured sequence of observations and in vitro or in vivo applications in duly authorized research models.
- "Local Jurisdiction": the country, state, or territory where the Researcher acquires, stores, transports, or uses the RUO Compounds.
- "Unauthorized Use": any use that departs from scientific research, including human consumption, animal consumption, unauthorized resale, diagnosis, or medical prescription.
- "NEXURA Parties": NEXURA, its directors, shareholders, employees, representatives, distributors, and affiliates.
- "COA": Certificate of Analysis specifying the purity, lot number, manufacturing date, and storage conditions of each compound.
§ 3. STATEMENT OF EXCLUSIVE USE FOR RESEARCH (RUO)
The Researcher declares and warrants that:
- All RUO Compounds will be used solely and exclusively for scientific research, laboratory analysis, in vitro experimentation, in vivo experimentation in models authorized by competent ethics committees, or technical-scientific development.
- The RUO Compounds will not be intended for direct or indirect human consumption, veterinary animal consumption, drug manufacturing, supplement formulation, clinical diagnosis, treatment of diseases, or therapeutic applications.
- The RUO Compounds have not been approved by any regulatory agency (FDA, EMA, INVIMA, ANMAT, COFEPRIS, ANVISA, AEMPS, or equivalents) for use in human beings, entailing unknown and unpredictable potential risks.
- The information on the Platform is strictly educational and scientific in nature and does not constitute medical advice, clinical guidance, or a prescription.
- Dosing protocols, schedules, routes of administration, and reconstitution procedures refer exclusively to research models and must not be interpreted as a guide for administration in human beings.
- RUO Compounds are potentially hazardous substances that require specialized handling, personal protective equipment, and controlled laboratory conditions.
§ 4. RESEARCHER'S RESPONSIBILITY — FULL SCOPE
The Researcher assumes full and unrestricted responsibility, and NEXURA may not be held liable under any legal theory, for:
- Verifying the legality of acquiring, importing, possessing, storing, transporting, handling, and disposing of the RUO Compounds in their Local Jurisdiction, including all required permits, licenses, and authorizations.
- Use, handling, labeling, reconstitution with protective equipment, and safe disposal in accordance with applicable biosafety regulations.
- Any consequence, damage, injury, illness, incapacity, or death resulting from the direct or indirect use of the RUO Compounds by the Researcher or third parties.
- Compliance with all legislation on scientific research, research ethics, data protection, biosafety, and control of substances.
- Any detention, confiscation, penalty, administrative proceeding, or legal action by authorities of any jurisdiction.
- The truthfulness and accuracy of all information provided to NEXURA during the acquisition and registration process.
- The consequences of sharing, transferring, or assigning the RUO Compounds or access to the Platform to unauthorized third parties.
- Proper storage in accordance with the instructions of the COA corresponding to the lot acquired.
§ 5. FULL EXONERATION OF NEXURA FROM LIABILITY
To the maximum extent permitted by law, the NEXURA Parties are expressly released from all liability for:
- Physical, psychological, property, or moral damages resulting from the use of the RUO Compounds outside the authorized in vitro research context.
- Adverse effects, allergic reactions, acute or chronic toxicity, drug interactions, dependence, or physiological consequences arising from exposure to or administration of the RUO Compounds.
- Economic losses arising from the detention, confiscation, or destruction of the RUO Compounds by customs or health authorities of any jurisdiction.
- The accuracy, completeness, currency, or applicability of the scientific information, protocols, and bibliographic references on the Platform.
- Technical failures, interruptions, software errors, security vulnerabilities, or data loss.
- Use that third parties make of the RUO Compounds or the information if the Researcher shared them.
- Supervening regulatory changes that alter the legal status of the RUO Compounds.
- Degradation of purity or biological activity due to inadequate storage or improper handling after delivery.
- Adverse, null, or unexpected research results arising from the use of the RUO Compounds.
- Damages from interaction of the RUO Compounds with other substances, medications, foods, or preexisting health conditions.
§ 6. CONFIDENTIALITY AND USE OF THE PLATFORM
The Researcher undertakes to maintain strict confidentiality. The following is expressly prohibited:
- Reproducing, publishing, distributing, or commercializing the Platform's content without the prior written authorization of NEXURA.
- Sharing the access code with unauthorized persons who have not completed the acquisition process.
- Using the content for purposes other than personal, non-commercial scientific research.
- Taking screenshots, recordings, or any extraction of protected content without express authorization.
- Reverse engineering, decompiling, or taking actions that breach the Platform's security systems.
- Using the Platform to prepare competing materials, academic publications, or derivative products without NEXURA's authorization.
Noncompliance will result in immediate termination of access and may lead to legal action under applicable intellectual property law.
§ 7. INTELLECTUAL PROPERTY
All content on the Platform —texts, protocols, calendars, anatomical illustrations, graphics, logos, trademarks, series names (Performance+, Longevity, Metabolic, Neuro, Recovery), source code, algorithms, and databases— is the exclusive property of NEXURA or its licensors, protected by the intellectual property laws of the Republic of Panama and international treaties (Berne Convention, TRIPS Agreement, WIPO treaties).
Access does not confer on the Researcher any right over NEXURA's intellectual property, except for a limited, personal, non-exclusive, non-transferable license to use the Platform during the period the access remains in effect.
§ 8. PERSONAL DATA PROTECTION
NEXURA processes the Researcher's personal data in accordance with its Privacy Policy and the regulations of the Republic of Panama. The Researcher consents to the processing of their data for:
- Access management and authentication on the Premium Platform.
- Sending reminders, notifications, and communications related to active research protocols and expiration alerts.
- Commercial, technical, and support communications related to NEXURA's products and services.
- Continuous improvement of the Platform and anonymized statistical analysis of usage behavior.
- Compliance with legal obligations and requirements of competent authorities.
The Researcher has the right of access, rectification, cancellation, and objection regarding the processing of their data, exercisable by contacting NEXURA through the Platform's official channels.
§ 9. REPRESENTATIONS AND WARRANTIES OF THE RESEARCHER
The Researcher declares and warrants that:
- Is of legal age under the legislation of their Local Jurisdiction, and in no case under 21 years of age at the time of accepting this Agreement.
- Has full legal capacity to contract and to assume the obligations contained in this Agreement.
- Acts on their own behalf or with sufficient authority to bind the entity they represent.
- Has sufficient knowledge in the relevant scientific field to understand the nature, characteristics, risks, and limitations of the RUO Compounds.
- Has consulted with competent health professionals, legal advisors, and scientists in their Local Jurisdiction before acquiring or accessing the information.
- Is not located in any jurisdiction where the acquisition, import, possession, or use of the RUO Compounds is expressly prohibited by law.
- Will not use the RUO Compounds or the Platform's information for illegal or fraudulent purposes, or purposes contrary to internationally recognized scientific ethics.
- Understands that noncompliance with these representations constitutes a serious breach and releases NEXURA from any liability arising from such noncompliance.
§ 10. QUALITY, CERTIFICATION, AND TRACEABILITY
NEXURA warrants that all RUO Compounds undergo quality control using validated High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) techniques, with a COA for each lot. Notwithstanding the foregoing, the Researcher acknowledges that:
- Purity and stability may be affected by inadequate storage conditions, incorrect reconstitution, or exposure to temperature, light, or humidity outside the specified ranges.
- NEXURA is not responsible for degradation or loss of activity caused by reasons attributable to the Researcher or the storage environment.
- Research results may vary and cannot be guaranteed, as they depend on methodological variables and external factors beyond NEXURA's control.
§ 11. TERMINATION OF ACCESS
NEXURA reserves the right to suspend or terminate access without prior notice and without liability in the following cases:
- Breach of any provision of this Agreement.
- Reasonable indications of Unauthorized Use of the RUO Compounds or of the Platform's information.
- False, misleading, or incorrect statements by the Researcher at any time.
- Request by competent authorities of any jurisdiction.
- Technical, information security, or Platform integrity reasons.
- Unilateral decision by NEXURA, with at least 7 days' prior notice, except in cases of urgency or security where termination may be immediate.
Termination does not release the Researcher from the confidentiality, waiver, and indemnification obligations, which survive such termination.
§ 12. AMENDMENTS TO THE AGREEMENT
NEXURA reserves the right to modify the terms by notifying the Researcher at least 15 calendar days in advance. Continued use of the Platform after notification shall constitute tacit and irrevocable acceptance of the new terms. If the Researcher does not accept the new terms, they must cease use and notify NEXURA in writing within the stated period.
§ 13. GOVERNING LAW AND JURISDICTION
This Agreement is governed exclusively by the laws of the Republic of Panama. For the resolution of disputes, the parties irrevocably submit to the jurisdiction of the competent courts of Panama City, expressly waiving any other forum or jurisdiction that may correspond to them.
If any provision is declared null or unenforceable by a competent court, the remaining provisions shall remain fully in force.
§ 14. INDEMNIFICATION
The Researcher agrees to indemnify, defend, and hold harmless the NEXURA Parties from any claim, damage, cost, or expense —including reasonable attorneys' fees and court costs— arising from:
- (i) breach of any provision of this Agreement;
- (ii) Unauthorized Use of the RUO Compounds or of the Platform's information;
- (iii) false, inaccurate, or incomplete statements by the Researcher;
- (iv) any act or omission of the Researcher that results in harm to third parties; or
- (v) any violation of third-party rights, including intellectual property, privacy, or regulatory rights.
§ 15. ENTIRE AGREEMENT
This Agreement, together with the General Terms of Sale, Privacy Policy, the COA for each lot, Technical Data Sheets, and RUO Statement, constitutes the entire agreement between the parties with respect to its subject matter and supersedes any prior understanding, oral or written. There is no other condition, warranty, or representation that modifies it, except for a written amendment signed by an authorized representative of NEXURA.
— END OF DOCUMENT — NEXURA BIO SYSTEMS S.A. — DOC: RUO-PLT-V3.1 — PANAMA, REPUBLIC OF PANAMA —
This acceptance is binding and irrevocable under Agreement RUO-PLT-V3.1.
By continuing you confirm that you have read and fully understood this Agreement.